Evinova today announced strategic collaborations with global life sciences companies Astellas Pharma Inc. ("Astellas"), AstraZeneca and Bristol Myers Squibb to accelerate their global clinical ...

Clay brings a distinguished track record in global project delivery and site relationship strategy. He has led large-scale ...

The emergence of AI and biosensors offers a chance to address inefficiencies in drug development.

Plasmalogen precursors for Alzheimer’s are named as first program candidate There are nutrients and dietary compounds ...

Q4 2025 Management View CEO Paul LaViolette stated that Pulse Biosciences is “creating a pulsed field ablation platform to completely shift how physicians treat disease” by advancing nanosecond pulsed ...

Drug Development Lessons for 2026 Drawn from 2025 Realities, Upcoming Webinar Hosted by Xtalks ...

Diversity in clinical trials matters for drug safety and efficacy—and for future medical advancements. Clinical trial ...

PALO ALTO, Calif.--(BUSINESS WIRE)--Science Exchange, the leading SaaS provider of supplier orchestration solutions for the life sciences industry, today announced the launch of its Clinical ...

New Appointments Reinforce Operational Readiness Across Finance, Regulatory Affairs, and Program Leadership Phio ...

Thermo Fisher Scientific has entered into a strategic data collaboration with Datavant aimed at expanding real-world data (RWD) interoperability and linkage across clinical research and development ...

Even when promising clinical trials exist, and the FDA allows expanded access, rare disease patients like my granddaughter ...